These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 21459342

  • 21. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
    Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, Hirohashi S.
    Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
    [Abstract] [Full Text] [Related]

  • 22. Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma.
    Kim H, Park YN.
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):813-29. PubMed ID: 25260310
    [Abstract] [Full Text] [Related]

  • 23. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
    Wang XY, Degos F, Dubois S, Tessiore S, Allegretta M, Guttmann RD, Jothy S, Belghiti J, Bedossa P, Paradis V.
    Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
    [Abstract] [Full Text] [Related]

  • 24. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
    Compagnon P, Grandadam S, Lorho R, Turlin B, Camus C, Jianrong Y, Lainé F, Meunier B, Deugnier Y, Boudjema K.
    Transplantation; 2008 Oct 27; 86(8):1068-76. PubMed ID: 18946344
    [Abstract] [Full Text] [Related]

  • 25. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L, Severi T, Cassiman D, Vander Borght S, Pirenne J, Nevens F, Verslype C, van Pelt J, Roskams T.
    Am J Surg Pathol; 2006 Nov 27; 30(11):1405-11. PubMed ID: 17063081
    [Abstract] [Full Text] [Related]

  • 26. Preneoplastic lesions in human hepatocarcinogenesis.
    Libbrecht L, Desmet V, Roskams T.
    Liver Int; 2005 Feb 27; 25(1):16-27. PubMed ID: 15698394
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
    Longerich T, Haller MT, Mogler C, Aulmann S, Lohmann V, Schirmacher P, Brand K.
    Pathol Res Pract; 2011 Jan 15; 207(1):8-14. PubMed ID: 20971570
    [Abstract] [Full Text] [Related]

  • 30. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.
    Nzeako UC, Goodman ZD, Ishak KG.
    Am J Gastroenterol; 1996 May 15; 91(5):879-84. PubMed ID: 8633575
    [Abstract] [Full Text] [Related]

  • 31. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T, Hoso M, Nakanuma Y.
    Mod Pathol; 1995 May 15; 8(4):371-9. PubMed ID: 7567933
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D, Schoelmerich J, Zuber-Jerger I.
    Z Gastroenterol; 2007 Oct 15; 45(10):1067-74. PubMed ID: 17924305
    [Abstract] [Full Text] [Related]

  • 35. Outcomes of small nodular lesions in heavy drinkers.
    Suzuki M, Maeyama S, Nishikawa K, Okuse N, Hashizume K, Mamada Y, Kobayashi Y, Okuse C, Takahashi Y, Osada T, Hayashi T, Yotuyanagi H, Suzuki H, Ogata S, Uchikoshi T, Iino S.
    Alcohol Clin Exp Res; 2002 Aug 15; 26(8 Suppl):55S-62S. PubMed ID: 12198376
    [Abstract] [Full Text] [Related]

  • 36. Squamous cell carcinoma antigen in human liver carcinogenesis.
    Guido M, Roskams T, Pontisso P, Fassan M, Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U, Rugge M.
    J Clin Pathol; 2008 Apr 15; 61(4):445-7. PubMed ID: 17893121
    [Abstract] [Full Text] [Related]

  • 37. Molecular signature of early hepatocellular carcinoma.
    Suriawinata A, Thung SN.
    Oncology; 2010 Jul 15; 78 Suppl 1():36-9. PubMed ID: 20616582
    [Abstract] [Full Text] [Related]

  • 38. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
    Lin CC, Lin CJ, Hsu CW, Chen YC, Chen WT, Lin SM.
    J Gastroenterol Hepatol; 2008 Jul 15; 23(7 Pt 2):e146-52. PubMed ID: 17532784
    [Abstract] [Full Text] [Related]

  • 39. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
    Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY.
    Hepatology; 2005 Oct 15; 42(4):809-18. PubMed ID: 16175600
    [Abstract] [Full Text] [Related]

  • 40. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
    Tátrai P, Somorácz A, Batmunkh E, Schirmacher P, Kiss A, Schaff Z, Nagy P, Kovalszky I.
    Am J Surg Pathol; 2009 Jun 15; 33(6):874-85. PubMed ID: 19194276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.